Calithera Biosciences, Inc.
Calithera Biosciences, Inc. (CALA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CALA · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Calithera Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CALA insider buying and selling by quarter
CALA insider selling · CALA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
CALA executive sell shares · CALA board member insider trading · CALA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 27, 2023 | PAKIANATHAN DEEPIKA Director | Sale | 1,172 | $452 | Form 4 |
| Jan 23, 2023 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 279 | $124 | Form 4 |
| Jan 23, 2023 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 79 | $35 | Form 4 |
| Jan 23, 2023 | Molineaux Susan PRESIDENT & CEO | Other | 526 | $235 | Form 4 |
| Jan 23, 2023 | Wong Stephanie See Remarks | Other | 317 | $141 | Form 4 |
| Jan 23, 2023 | Molineaux Christopher SR. VP, DEVELOPMENT | Other | 217 | $97 | Form 4 |
| Jan 21, 2022 | Parlati Francesco SR. VP, RESEARCH | Other | 4,794 | $2K | Form 4 |
| Jan 21, 2022 | Wong Stephanie See Remarks | Other | 5,586 | $3K | Form 4 |
| Jan 21, 2022 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 4,794 | $2K | Form 4 |
| Jan 21, 2022 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 666 | $327 | Form 4 |
| Jan 4, 2022 | Parlati Francesco SR. VP, RESEARCH | Other | 18,077 | $12K | Form 4 |
| Jan 4, 2022 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 3,855 | $3K | Form 4 |
| Jan 4, 2022 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 18,077 | $12K | Form 4 |
| Jan 4, 2022 | Wong Stephanie See Remarks | Other | 18,077 | $12K | Form 4 |
| Nov 10, 2021 | Orford Keith Director | Sale | 30,000 | $26K | Form 4 |
| Nov 11, 2021 | Orford Keith Director | Sale | 48,190 | $42K | Form 4 |
| Nov 10, 2021 | Molineaux Susan PRESIDENT & CEO · Director | Purchase | 100,000 | $85K | Form 4 |
| Nov 10, 2021 | DRACHMAN JONATHAN G Director | Purchase | 200,000 | $172K | Form 4 |
| Nov 10, 2021 | Molineaux Christopher SR. VP, DEVELOPMENT | Purchase | 100,000 | $85K | Form 4 |
| Nov 5, 2021 | Orford Keith Director | Award | 30,000 | — | Form 4 |
| Nov 9, 2021 | Orford Keith Director | Sale | 51,810 | $44K | Form 4 |
| Nov 5, 2021 | Molineaux Christopher SR. VP, DEVELOPMENT | Award | 12,000 | — | Form 4 |
| Nov 5, 2021 | Sjogren Eric SR. VP, DRUG DISCOVERY | Award | 30,000 | — | Form 4 |
| Nov 8, 2021 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 15,566 | $14K | Form 4 |
| Nov 5, 2021 | Wong Stephanie See Remarks | Award | 30,000 | — | Form 4 |
Molineaux Christopher
SR. VP, DEVELOPMENT
Date
Jan 23
Shares
217
Price
$0.45
Value
$97
Sjogren Eric
SR. VP, DRUG DISCOVERY
Date
Jan 21
Shares
4,794
Price
$0.49
Value
$2K
Kuriakose Emil
CHIEF MEDICAL OFFICER
Date
Jan 21
Shares
666
Price
$0.49
Value
$327
Parlati Francesco
SR. VP, RESEARCH
Date
Jan 4
Shares
18,077
Price
$0.66
Value
$12K
Kuriakose Emil
CHIEF MEDICAL OFFICER
Date
Jan 4
Shares
3,855
Price
$0.66
Value
$3K
Sjogren Eric
SR. VP, DRUG DISCOVERY
Date
Jan 4
Shares
18,077
Price
$0.66
Value
$12K
Molineaux Susan
PRESIDENT & CEO · Director
Date
Nov 10
Shares
100,000
Price
$0.85
Value
$85K
DRACHMAN JONATHAN G
Director
Date
Nov 10
Shares
200,000
Price
$0.86
Value
$172K
Molineaux Christopher
SR. VP, DEVELOPMENT
Date
Nov 10
Shares
100,000
Price
$0.85
Value
$85K
Molineaux Christopher
SR. VP, DEVELOPMENT
Date
Nov 5
Shares
12,000
Price
—
Value
—
Sjogren Eric
SR. VP, DRUG DISCOVERY
Date
Nov 8
Shares
15,566
Price
$0.87
Value
$14K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CALA insider trading
CALA insider trades
Calithera Biosciences, Inc. (CALA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CALA. Over the past 12 months, 0 insiders have filed transactions with the SEC. CALA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Calithera Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CALA insider trading · 5 questionsThe insiders of Calithera Biosciences, Inc. (CALA) include executives and directors such as CALA, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026